The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.80
Bid: 147.00
Ask: 147.80
Change: 2.00 (1.37%)
Spread: 0.80 (0.544%)
Open: 144.00
High: 147.80
Low: 144.00
Prev. Close: 145.80
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Statement

25 Apr 2017 07:00

ELEMENTIS PLC - AGM Trading Statement

ELEMENTIS PLC - AGM Trading Statement

PR Newswire

London, April 24

25 April 2017

AGM / Trading Statement

A positive start to the year with trading strong across the businesses.

Ahead of today’s Annual General Meeting, Elementis plc (ELM.L, the “Company" or the “Group"), the Global Specialty Chemicals Company, today issues its trading update for the three months ended 31 March 2017.Trading for the Group in the first quarter (Q1) was underpinned by stronger demand across most of our markets compared to Q1 2016. In Specialty Products, our Coatings business sector started well and we saw notably strong growth in our Personal Care and Energy business sectors. In our Chromium segment there were some indications of improved demand outside North America. In Surfactants we are benefiting from short term favourable pricing conditions which are not expected to continue indefinitely. This represents a positive start to the year and we remain on track to grow operating profit across our three segments in 2017.On 20 March 2017, we announced the sale of our non-core US colourants business and the closure of our Jersey City facility as part of our strategy to review our non-core and disadvantaged assets. On 24 March 2017, we completed our acquisition of SummitReheis and have started the integration process. It is a high quality business and we are delighted to have it in our portfolio. Commenting on the Company’s performance Paul Waterman, CEO, said: “We are off to a good start in 2017 as trading was strong across our businesses. Last November we committed to reignite growth at Elementis by focusing on four strategic priorities: pursuing the best growth opportunities, transforming our global supply chain, innovating for distinctiveness and high margins and creating a culture of high performance. We are excited to integrate SummitReheis into our Personal Care sector and look forward to completing this by the end of the year. Overall, while uncertainties exist we believe continued focus on implementing our strategy will underpin continued progress in 2017.” ENDS

Enquiries:

Elementis+ 44 (0) 207 067 2999
Paul Waterman, Chief Executive Officer Ralph Hewins, Chief Financial Officer
FTI Consulting+ 44 (0) 203 727 1000
Deborah Scott
Matthew Cole
Date   Source Headline
8th May 202411:08 amRNSDirector/PDMR Shareholding
3rd May 202411:46 amRNSHolding(s) in Company
1st May 202410:06 amRNSTotal Voting Rights
30th Apr 202411:36 amRNSResult of AGM
30th Apr 20247:00 amRNSFirst quarter trading update
29th Apr 202412:13 pmRNSResponse to open letter from Gatemore
12th Apr 202411:33 amRNSDirector/PDMR Shareholding
12th Apr 202411:28 amRNSDirector/PDMR Shareholding
9th Apr 20246:04 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSAnnual Financial Report & Notice of AGM
19th Mar 20243:02 pmRNSAdditional Listing
15th Mar 20241:00 pmRNSDirectorate Change
12th Mar 20244:38 pmRNSDirector/PDMR Shareholding
12th Mar 20244:33 pmRNSDirector/PDMR Shareholding
8th Mar 20245:56 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirectorate changes
7th Mar 20247:00 amRNSPreliminary results year ended 31 December 2023
1st Mar 20249:30 amRNSBlock listing Interim Review
18th Jan 20247:00 amRNSTrading Update
2nd Jan 20249:45 amRNSTotal Voting Rights
1st Dec 202310:46 amRNSTotal Voting Rights
30th Nov 20239:38 amRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNS2023 Capital Markets Day
1st Nov 20239:46 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSThird Quarter Trading Update
2nd Oct 20239:34 amRNSTotal Voting Rights
20th Sep 202312:09 pmRNSResponse to open letter from Franklin Templeton
12th Sep 20233:13 pmRNSDirector Declaration
8th Sep 20239:30 amRNSHolding(s) in Company
1st Sep 20239:49 amRNSBlock listing Interim Review
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding
22nd Mar 20234:02 pmRNSAnnual Financial Report & Notice of AGM
17th Mar 20232:58 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.